Efficiency of rituximab in ANCA-associated vasulitis in comparison with standard induction and maintanance treatment

Abstract

Commentary NEJM 369,2013,417-427 Cyclophosphamide in combination with corticosteroids was more than 40 years, the standard induction therapy for ANCA-associated vaskulitidy.Studie RAVE and RITUXVAS but demonstrated that rituximab induces remission as effectively, in patients with relapsed AAV is even more effective

Keywords

• Cyclophosphamide
• corticosteroids
• ANCA
• rituximab